Table 3.
Distribution of E2F2 polymorphism genotypes in the analyzed patient, controls, and cohort groups.
| SNP ID | Genotypes | OSCC and OPSCC+control, n | OSCC and OPSCC, n | Control, n |
|---|---|---|---|---|
| rs6667575 | G/G | 84 | 46 | 38 |
| A/G | 89 | 36 | 53 | |
| A/A | 18 | 10 | 8 | |
| p value | ≤1 | ≤1 | ≤1 | |
| rs3218121 | G/G | 80 | 80 | 0 |
| A/G | 82 | 3 | 79 | |
| A/A | 31 | 12 | 19 | |
| p value | ≤1 | ≤0.001 | ≤0.001 | |
| rs3218211 | A/A | 51 | 25 | 26 |
| G/A | 90 | 40 | 50 | |
| G/G | 51 | 28 | 23 | |
| p value | ≤1 | ≤1 | ≤1 | |
| rs3218148 | G/G | 32 | 15 | 17 |
| A/G | 105 | 48 | 57 | |
| A/A | 53 | 30 | 23 | |
| p value | ≤1 | ≤1 | ≤1 | |
| rs3218203 | C/C | 128 | 65 | 63 |
| G/C | 62 | 30 | 32 | |
| G/G | 2 | 0 | 2 | |
| p value | ≤0.1 | ≤1 | ≤1 |